An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
Yue ChenZhi-Yong LiGuan-Qun ZhouYing SunPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
IRGPI is a promising biomarker to distinguish the prognosis, the molecular and immune characteristics, and the immune benefit from ICI therapy in HNSCC.